NGMD — NuGen Medical Devices Cashflow Statement
0.000.00%
Last trade - 00:00- CA$13.62m
- CA$23.25m
- CA$1.01m
Annual cashflow statement for NuGen Medical Devices, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -7.11 | -5.58 | -9.36 | -5.23 |
| Depreciation | ||||
| Non-Cash Items | 2.46 | 2.19 | 2.69 | 0.206 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.235 | 0.604 | -0.734 | -0.34 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -4.1 | -2.13 | -6.71 | -4.71 |
| Capital Expenditures | -0.004 | -0.001 | -0.003 | -0.01 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0.005 | 0 | -0.05 | -0.002 |
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 0.002 | -0.001 | -0.053 | -0.012 |
| Financing Cash Flow Items | 0 | -0.075 | — | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 5.58 | 0.514 | 7.1 | 11.2 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 1.47 | -1.62 | 0.333 | 6.48 |